Nicholas Investment Partners’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
Nicholas Investment Partners's BLUE Position: Q3 2018 in Review
Nicholas Investment Partners sold out of bluebird bio (BLUE) in Q3 2018, closing a stake of 3,297 shares — an estimated $6.7M sold.
Nicholas Investment Partners first reported a position in BLUE in Q4 2014 and held it in 14 quarters. The position peaked at $10.1M in Q4 2017. 288 funds tracked by Wall St. Rank hold BLUE as of Q3 2018.
- Nicholas Investment Partners reported no remaining bluebird bio position as of Q3 2018 after selling out during the quarter.
- Nicholas Investment Partners sold 3,297 bluebird bio shares in Q3 2018, an estimated $6.7M.
- Nicholas Investment Partners first reported a position in bluebird bio in Q4 2014 and held it in 14 quarters.
- Nicholas Investment Partners's bluebird bio position peaked at $10.1M in Q4 2017.
- 288 funds tracked by Wall St. Rank held bluebird bio as of Q3 2018.
Based on Nicholas Investment Partners's 13F filing for Q3 2018, filed 14 Nov 2018.